ACV Auctions (ACVA) CSO trims stake under 10b5-1 plan
Rhea-AI Filing Summary
ACV Auctions Inc. (ACVA) – Form 4 insider transaction
Chief Sales Officer Michael Waterman exercised 21,429 employee stock options at an exercise price of $0.14 on 07/08/2025 and immediately sold 34,339 common shares at a weighted-average price of $16.05 under a pre-established Rule 10b5-1 plan. The sequence results in a net reduction of 12,910 shares (≈3% of his direct stake). Following the transactions, Waterman directly owns 379,957 common shares—worth roughly $6.1 million at the sale price—and retains 259,835 unexercised options.
The filing discloses no company-level financial metrics, corporate events, or additional insider activity. Given the modest scale relative to total shares outstanding and Waterman’s sizeable remaining position, the market impact is likely limited, though investors may view the sale as a mild bearish signal.
Positive
- None.
Negative
- Insider sold 34,339 shares (~$0.55 million), trimming direct ownership by about 3%, which some investors may interpret as a modestly negative signal.
Insights
TL;DR: Small insider sale; neutral impact given minimal stake reduction.
The 34,339-share disposition represents under 3% of Waterman’s post-sale holdings and is executed via a 10b5-1 plan, mitigating concerns of opportunistic selling. Proceeds of roughly $0.55 million contrast with his remaining ~$6 million equity exposure, suggesting continued alignment with shareholder interests. The option exercise at a de-minimis strike is routine. In isolation, the activity does not materially alter ACVA’s investment thesis or signal fundamental weakness. I classify the filing as informational with negligible market impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 21,429 | $0.00 | -- |
| Exercise | Common Stock | 21,429 | $0.14 | $3K |
| Sale | Common Stock | 34,339 | $16.05 | $551K |
Footnotes (1)
- Shares sold pursuant to a Rule 10b5-1 trading plan enter into on December 10, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. One-fourth (1/4th) of the shares subject to the option award vested on July 1, 2018, and thereafter one-forty-eighths of the shares subject to the option award vested monthly, subject to the Reporting Person's continuous service.
